The Pharmaceuticals in Dosage Market Size Value Per Capita in France experienced fluctuations from 2012 to 2022. Starting at $1.5 thousand in 2012, it saw a declining trend until 2017, reaching the lowest value of $1.1 thousand. However, a mild recovery was observed from 2018 to 2021, with values rising to $1.19 thousand, before dropping to $1.06 thousand in 2022. Year-on-year variations over the last two years have shown a slight decrease from 2021 to 2022 by 10.92%. The Compound Annual Growth Rate (CAGR) over the last five years (2017-2022) stands at approximately 1.15%, reflecting a slight overall decline.
Future trends to watch for include the potential impact of innovative pharmaceuticals, personalized medicine, and regulatory changes on market value. Improved healthcare policies and advancements in biotechnology may stimulate market growth, while an aging population could increase demand for pharmaceuticals in dosage forms.
How does France rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 6 | 6 France | 1,030 | 2023 | |||
| 7 | 7 Austria | 1,010 | 2023 | View data | ||
| 8 | 8 Israel | 990.06 | 2023 | View data | ||
